These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15588690)

  • 21. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.
    Guttman-Yassky E; Lowes MA; Fuentes-Duculan J; Whynot J; Novitskaya I; Cardinale I; Haider A; Khatcherian A; Carucci JA; Bergman R; Krueger JG
    J Allergy Clin Immunol; 2007 May; 119(5):1210-7. PubMed ID: 17472813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CC-10004 .
    Khobzaoui M; Gutke HJ; Burnet M
    Curr Opin Investig Drugs; 2005 May; 6(5):518-25. PubMed ID: 15912967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural ingredients in atopic dermatitis and other inflammatory skin disease.
    Dohil MA
    J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s128-32. PubMed ID: 24002161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
    Simon D; Vassina E; Yousefi S; Braathen LR; Simon HU
    Allergy; 2005 Jul; 60(7):944-51. PubMed ID: 15932386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.
    Fischer M; Harvima IT; Carvalho RF; Möller C; Naukkarinen A; Enblad G; Nilsson G
    J Clin Invest; 2006 Oct; 116(10):2748-56. PubMed ID: 16964309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model.
    Wang G; Fyhrquist-Vanni N; Wolff H; Dieu-Nosjean MC; Kemeny L; Homey B; Lauerma AI; Alenius H
    Int Arch Allergy Immunol; 2008; 147(1):41-51. PubMed ID: 18446052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokines as therapeutic targets in skin inflammation.
    Wittmann M; McGonagle D; Werfel T
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):443-51. PubMed ID: 25164568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs.
    Albanesi C; Pastore S
    Curr Drug Metab; 2010 Mar; 11(3):210-27. PubMed ID: 20406192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The coexistence of atopic dermatitis and psoriasis in a 12 months-old girl].
    Kamer B; Rotsztejn H; Kulig A; Raczyńska J; Piotrowicz M; Kulig K; Pyziak K
    Pol Merkur Lekarski; 2005 Oct; 19(112):542-4. PubMed ID: 16379321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
    Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
    Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of skin diseases in childhood.
    Morley N
    Practitioner; 1970 Jan; 204(219):97-108. PubMed ID: 4243744
    [No Abstract]   [Full Text] [Related]  

  • 32. Facing psoriasis and atopic dermatitis: are there more similarities or more differences?
    Wilsmann-Theis D; Hagemann T; Jordan J; Bieber T; Novak N
    Eur J Dermatol; 2008; 18(2):172-80. PubMed ID: 18424378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key developments in dermatology.
    Stollery NA
    Practitioner; 2003 Feb; 247(1643):75, 79, 82 passim. PubMed ID: 12621801
    [No Abstract]   [Full Text] [Related]  

  • 34. Advances in dermatology.
    Marks R
    Practitioner; 1982 Oct; 226(1372):1657-63. PubMed ID: 6217459
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytokines in dermatology.
    Holman DM; Kalaaji AN
    J Drugs Dermatol; 2006 Jun; 5(6):520-4. PubMed ID: 16774103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exploring new therapeutic approaches to the treatment of inflammatory disorders--lipoxins].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):578-80. PubMed ID: 16161960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
    Dastidar SG; Rajagopal D; Ray A
    Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
    Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
    J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery.
    Petersen TK
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):104-15. PubMed ID: 16918710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nurse prescribing and dermatology.
    Courtenay M
    Nurs Times; 2002 Jul 23-29; 98(30):53-4. PubMed ID: 12168273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.